Summary
The main form of fibronectin (FN) encountered by tumor cells in vivo is cellular FN (cFN), which differs structurally and functionally from the commonly used plasma FN (pFN). We compared the effects of cFN and pFN on the ovarian carcinoma lines OVCAR-3 and SKOV-3 and on cultures of normal ovarian surface epithelium, which is the precursor of the epithelial ovarian carcinomas. Ovarian surface epithelial cells and SKOV-3 cells attached and spread faster on cFN than on pFN. On cFN, SKOV-3 migration was enhanced compared with pFN or plastic. In a matrigel transfilter assay, cFN strongly inhibited SKOV-3 invasion, whereas pFN did not. In contrast to SKOV-3, OVCAR-3 cells adhered faster on FN than on plastic but did not discriminate between cFN and pFN, and they did not migrate or invade matrigel either with or without FN. In both carcinoma lines, proliferation was unaffected by either FN. The results show profound differences in the responses to cFN and pFN by two invasive ovarian carcinoma lines. Because cFN is the main type that cancer cells encounter in vivo, extrapolations from culture data to in vivo events should preferably be based on studies using this form of FN.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Akiyama, S. K. Integrins in cell adhesion and signaling. Hum. Cell 9:181–186; 1996.
Akiyama, S. K.; Olden, K.; Yamada, K. M. Fibronectin and integrins in invasion and metastasis. Cancer Metastasis Rev. 14:173–189; 1995.
Albini, A. Tumor and endothelial cell invasion of basement membranes. The matrigel chemoinvasion assay as a tool for dissecting molecular mechanisms. Pathol. Oncol. Res. 4:230–241; 1998.
Auersperg, N.; Wong, A. S.; Choi, K. C.; Kang, S. K.; Leung, P. C. Ovarian surface epithelium: biology, endocrinology, and pathology. Endocr. Rev. 22:255–288; 2001.
Cannistra, S. A.; Ottensmeier, C.; Niloff, J.; Orta, B.; DiCarlo, J. Expression and function of beta 1 and alpha v beta 3 integrins in ovarian cancer. Gynecol. Oncol. 58:216–225; 1995.
Couchman, J. R.; Austria, M. R.; Woods, A. Fibronectin-cell interactions. J. Invest. Dermatol. 94:7S-14S; 1990.
Cruet, S.; Salamanca, C.; Mitchell, G. W.; Auersperg, N. Alphavbeta3 and vitronectin expression by normal ovarian surface epithelial cells: role in cell adhesion and cell proliferation. Gynecol. Oncol. 75:254–260; 1999.
Esparza, J.; Vilardell, C.; Calvo, J., et al. Fibronectin upregulates gelatinase B (MMP-9) and induces coordinated expression of gelatinase A (MMP-2) and its activator MT1-MMP (MMP-14) by human T lymphocyte cell lines. A process repressed through RAS/MAP kinase signaling pathways. Blood 94:2754–2766; 1999.
french-Constant, C. Alternative splicing of fibronectin—many different proteins but few different functions. Exp. Cell Res. 221:261–271; 1995.
Giancotti, F. G.; Ruoslahti, E. Elevated levels of the alpha 5 beta 1 fibronectin receptor suppress the transformed phenotype of Chinese hamster ovary cells. Cell 60:849–859; 1990.
Goodheart, C. R.; Silverman, R. H. Cellular and plasma fibronectin. SIM Ind. Microbiol. News 41:266–272; 1991.
Hagios, C.; Lochter, A.; Bissell, M. J. Tissue architecture: the ultimate regulator of epithelial function? Philos. Trans. R. Soc. Lond. B Biol. Sci. 353:857–870; 1998.
Humphries, M. J.; Olden, K.; Yamada, K. M. A synthetic peptide from fibronectin inhibits experimental metastasis of murine melanoma cells. Science 233:467–470; 1986.
Kornblihtt, A. R.; Vibe-Pedersen, K.; Baralle, F. E. Human fibronectin: cell specific alternative mRNA splicing generates polypeptide chains differing in the number of internal repeats. Nucleic Acids Res. 12:5853–5868; 1984.
Kruk, P. A.; Uitto, V. J.; Firth, J. D.; Dedhar, S.; Auersperg, N. Reciprocal interactions between human ovarian surface epithelial cells and adjacent extracellular matrix. Exp. Cell Res. 215:97–108; 1994.
Lessan, K.; Aguiar, D. J.; Oegema, T.; Siebenson, L.; Skubitz, A. P. CD44 and betal integrin mediate ovarian carcinoma cell adhesion to peritoneal mesothelial cells. Am. J. Pathol. 154:1525–1537; 1999.
Manabe, R.; Ohe, N.; Maeda, T.; Fukuda, T.; Sekiguchi, K. Modulation of cell-adhesive activity of fibronectin by the alternatively spliced EDA segment. J. Cell Biol. 139:295–307; 1997.
McCarthy, J. B.; Hagen, S. T.; Furcht, L. T. Human fibronectin contains distinct adhesion- and motility-promoting domains for metastatic melanoma cells. J. Cell Biol. 102:179–188; 1986.
Nabeshima, K.; Asada, Y.; Inoue, T., et al. Modulation of E-cadherin expression in TPA-induced cell motility: well-differentiated human adenocarcinoma cells move as coherent sheets associated with phosphorylation of E-cadherin-catenin complex. Lab. Invest. 76:139–151; 1997.
Nabeshima, K.; Inoue, T.; Shimao, Y.; Kataoka, H.; Koono, M. TPA-induced cohort migration of well-differentiated human rectal adenocarcinoma cells: cells move in a RGD-dependent manner on fibronectin produced by cells, and phosphorylation of E-cadherin/catenin complex is induced independently of cell-extracellular matrix interactions. Virchows Arch. 433:243–253; 1998.
Petersen, T. E.; Thogersen, H. C.; Skorstengaard, K., et al. Partial primary structure of bovine plasma fibronectin: three types of internal homology. Proc. Natl. Acad. Sci. USA 80:137–141; 1983.
Ruoslahti, E.; Pierschbacher, M. D. New perspectives in cell adhesion: RGD and integrins. Science 238:491–497; 1987.
Schwarzbauer, J. E. Alternative splicing of fibronectin: three variants, three functions. Bioessays 13:527–533; 1991.
Shimao, Y.; Nabeshima, K.; Inoue, T.; Koono, M. Role of fibroblasts in HGF/SF-induced cohort migration of human colorectal carcinoma cells: fibroblasts stimulate migration associated with increased fibronectin production via upregulated TGF-betal. Int. J. Cancer 82:449–458; 1999.
Ueoka, Y.; Kato, K.; Kuriaki, Y., et al. Hepatocyte growth factor modulates motility and invasiveness of ovarian carcinomas via Ras-mediated pathway. Br. J. Cancer 82:891–899; 2000.
Westerlund, A.; Hujanen, E.; Hoyhtya, M.; Puistola, U. Turpeenniemi-Hujanen, T. Ovarian cancer cell invasion is inhibited by paclitaxel. Clin. Exp. Metastasis 15:318–328; 1997.
Wong, A. S.; Pelech, S. L.; Woo, M. M., et al. Coexpression of hepatocyte growth factor-Met: an early step in ovarian carcinogenesis? Oncogene 20:1318–1328; 2001.
Woods, A.; Couchman, J. R. Syndecan 4 heparan sulfate proteoglycan is a selectively enriched and widespread focal adhesion component. Mol. Biol. Cell. 5:183–192; 1994.
Yamada, K. M.; Kennedy, D. W. Fibroblast cellular and plasma fibronectins are similar but not identical. J. Cell Biol. 80:492–498; 1979.
Zardi, L.; Carnemolla, B.; Siri, A., et al. Transformed human cells produce a new fibronectin isoform by preferential alternative splicing of a previously unobserved exon. EMBO J. 6:2337–2342; 1987.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Zand, L., Feng, Q., Roskelley, C.D. et al. Differential effects of cellular fibronectin and plasma fibronectin on ovarian cancer cell adhesion, migration, and invasion. In Vitro Cell.Dev.Biol.-Animal 39, 178–182 (2003). https://doi.org/10.1007/s11626-003-0013-0
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/s11626-003-0013-0